Showing results (1191-1200 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|April 10, 2019
Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic ReviewKamyar Keramatian, Trisha Chakrabarty, Lakshmi N YathamCNS Drugs|April 17, 2019
Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic TargetsKristian Agmund Haanes, Lars EdvinssonCNS Drugs|September 24, 2018
Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective AnalysisMark Gudesblatt, Karl Wissemann, Myassar Zarif, et al.CNS Drugs|June 3, 2018
Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between AgentsMichael W Jann, Scott R PenzakCNS Drugs|July 18, 2018
Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination SurveyNatalie Bareis, Trisha A Sando, Briana Mezuk, et al.CNS Drugs|July 21, 2018
Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?Seok Jong Chung, Han Soo Yoo, Hye Sun Lee, et al.CNS Drugs|July 21, 2018
Correction to: Treatment Strategies for Dravet SyndromeKelly G Knupp, Elaine C WirrellCNS Drugs|August 9, 2018
Amantadine Extended-Release (GOCOVRI™): A Review in Levodopa-Induced Dyskinesia in Parkinson's DiseaseJulia Paik, Susan J KeamCNS Drugs|May 9, 2018
Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical ReviewP Molero, J A Ramos-Quiroga, R Martin-Santos, et al.Pageof 211